Detalhe da pesquisa
1.
Two staged phase II clinical trial of Eribulin monotherapy in advanced or recurrent cervical cancer.
Gynecol Oncol
; 173: 49-57, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37079977
2.
Gut microbiome associations with breast cancer risk factors and tumor characteristics: a pilot study.
Breast Cancer Res Treat
; 182(2): 451-463, 2020 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-32468338
3.
Second-line lenvatinib in patients with recurrent endometrial cancer.
Gynecol Oncol
; 156(3): 575-582, 2020 03.
Artigo
Inglês
| MEDLINE | ID: mdl-31955859
4.
Efficacy of pegylated liposomal doxorubicin maintenance therapy in platinum-sensitive recurrent epithelial ovarian cancer: a retrospective study.
Arch Gynecol Obstet
; 299(6): 1641-1649, 2019 06.
Artigo
Inglês
| MEDLINE | ID: mdl-30824986
5.
Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy.
N Engl J Med
; 372(10): 923-32, 2015 03 05.
Artigo
Inglês
| MEDLINE | ID: mdl-25738668
6.
Randomized Phase II Study of Ramucirumab or Icrucumab in Combination with Capecitabine in Patients with Previously Treated Locally Advanced or Metastatic Breast Cancer.
Oncologist
; 22(3): 245-254, 2017 03.
Artigo
Inglês
| MEDLINE | ID: mdl-28220020
7.
Accuracy of Contrast-Enhanced Ultrasound Compared With Magnetic Resonance Imaging in Assessing the Tumor Response After Neoadjuvant Chemotherapy for Breast Cancer.
J Ultrasound Med
; 36(5): 901-911, 2017 May.
Artigo
Inglês
| MEDLINE | ID: mdl-28150325
8.
Value of routine staging imaging studies for patients with stage III breast cancer.
J Surg Oncol
; 114(8): 917-921, 2016 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-27642105
9.
Second-line dovitinib (TKI258) in patients with FGFR2-mutated or FGFR2-non-mutated advanced or metastatic endometrial cancer: a non-randomised, open-label, two-group, two-stage, phase 2 study.
Lancet Oncol
; 16(6): 686-94, 2015 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-25981814
10.
Phase I/II study of pilaralisib (SAR245408) in combination with trastuzumab or trastuzumab plus paclitaxel in trastuzumab-refractory HER2-positive metastatic breast cancer.
Breast Cancer Res Treat
; 149(1): 151-61, 2015 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-25537644
11.
Two schedules of etirinotecan pegol (NKTR-102) in patients with previously treated metastatic breast cancer: a randomised phase 2 study.
Lancet Oncol
; 14(12): 1216-25, 2013 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-24095299
12.
Eribulin mesylate versus ixabepilone in patients with metastatic breast cancer: a randomized Phase II study comparing the incidence of peripheral neuropathy.
Breast Cancer Res Treat
; 140(2): 341-51, 2013 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-23877339
13.
Listening in on difficult conversations: an observational, multi-center investigation of real-time conversations in medical oncology.
BMC Cancer
; 13: 455, 2013 Oct 04.
Artigo
Inglês
| MEDLINE | ID: mdl-24093624
14.
A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab.
Breast Cancer Res Treat
; 133(3): 1057-65, 2012 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-22418700
15.
Comparison of molecular subtyping with BluePrint, MammaPrint, and TargetPrint to local clinical subtyping in breast cancer patients.
Ann Surg Oncol
; 19(10): 3257-63, 2012 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-22965266
16.
Phase II study of gemcitabine and docetaxel in recurrent platinum resistant ovarian cancer.
Cancer Invest
; 30(4): 295-9, 2012 May.
Artigo
Inglês
| MEDLINE | ID: mdl-22468744
17.
A phase II evaluation of lapatinib in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: a gynecologic oncology group study.
Gynecol Oncol
; 124(3): 569-74, 2012 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-22037316
18.
Effect of Chemotherapy on the Gut Microbiome of Breast Cancer Patients During the First Year of Treatment.
Breast Cancer (Dove Med Press)
; 14: 433-451, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36532254
19.
Bariatric surgery in patients with breast and endometrial cancer in California: population-based prevalence and survival.
Surg Obes Relat Dis
; 18(1): 42-52, 2022 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-34740554
20.
Phase II Study of Taselisib in PIK3CA-Mutated Solid Tumors Other Than Breast and Squamous Lung Cancer: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol I.
JCO Precis Oncol
; 6: e2100424, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-35138919